Raymond James & Associates Gsk PLC Call Options Transaction History

Raymond James & Associates

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $895,664 - $1.02 Million	21,300 Added 26.96%	100,300 $71,000
Q1 2022 May 11, 2022	BUY	$40.23 - $47.74 $40,230 - $47,740	1,000 Added 1.28%	79,000 $16,000
Q4 2021 Feb 08, 2022	SELL	$38.88 - $45.31 $711,504 - $829,173	-18,300 Reduced 19.0%	78,000 $43,000
Q3 2021 Nov 02, 2021	BUY	$38.79 - $43.16 $50,427 - $56,107	1,300 Added 1.37%	96,300 $19,000
Q2 2021 Aug 11, 2021	BUY	$36.52 - $41.46 $2.87 Million - $3.25 Million	78,500 Added 475.76%	95,000 $38,000
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $2.21 Million - $2.59 Million	-64,800 Reduced 79.7%	16,500 $20,000
Q3 2020 Nov 04, 2020	BUY	$38.11 - $42.99 $41,921 - $47,289	1,100 Added 1.37%	81,300 $12,000
Q2 2020 Jul 28, 2020	BUY	$37.87 - $43.58 $113,609 - $130,740	3,000 Added 3.89%	80,200 $20,000
Q1 2020 Apr 21, 2020	SELL	$32.47 - $48.83 $19,482 - $29,298	-600 Reduced 0.77%	77,200 $39,000
Q4 2019 Feb 12, 2020	SELL	$42.0 - $48.25 $100,800 - $115,800	-2,400 Reduced 2.99%	77,800 $195,000
Q3 2019 Nov 07, 2019	BUY	$40.46 - $43.52 $105,196 - $113,152	2,600 Added 3.35%	80,200 $44,000
Q1 2019 May 06, 2019	SELL	$38.57 - $42.69 $38,570 - $42,690	-1,000 Reduced 1.27%	77,600 $12,000
Q4 2018 Feb 11, 2019	SELL	$37.8 - $42.69 $45,360 - $51,228	-1,200 Reduced 1.5%	78,600 $4,000
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $15,900 - $17,076	-400 Reduced 0.5%	79,800 $4,000
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $566,423 - $611,468	14,300 Added 21.7%	80,200 $4,000
Q2 2017 Aug 14, 2017	BUY	N/A	65,900	65,900 $27,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.